Back to top

ISHARES NASDAQ BIOTECHNOLOGY: (NASD : IBB)

(U.S : NASD) As of Apr 17, 2014 03:59 PM ET

 Add to portfolio

$222.16 USD

-0.57 (-0.26%)

Volume: 2,970,974

Zacks ETF Rank: 1 - Strong Buy [?] 1        

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Premium - The only way to get access to the Zacks Rank

ETF Quote Details

Previous Close 222.73
Open 221.39
Bid 222.12
Ask 222.52
Day Low-High 220.44-226.39
52wk Low-High 163.41-275.40
Volume 2,970,974
NAV (month end) NA

Zacks Premium Research for IBB

Zacks ETF Rank [?] Strong Buy 1
ETF Risk [?] High
ETF Research Report

Learn to Profit from the Zacks Rank

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Premium - The only way to get access to the Zacks Rank

ETF Expense Ratio

Expense Ratio 0.48%
Dividend (Yield) $0.07 (0.03%)
Issuer BLACKROCK

Benchmark for IBB

NASDAQ BIOTECHNOLOGY

The NASDAQ Biotechnology Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals which also meet other eligibility criteria determined by the Funds Index Provider, NASDAQ OMX Group, Inc., including minimum market capitalization and liquidity requirements.

Fund Summary for IBB

ISHARES NASDAQ BIOTECHNOLOGY

The iShares Nasdaq Biotechnology Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index